Collections:
Other Resources:
DOI: 10.2217/fon-2021-0923
Paper Summary:
Title: MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer
Author(s): Cho, Byoung Chul (author);Felip, Enriqueta (author);Hayashi, Hidetoshi (author);Thomas, Michael (author);Lu, Shun (author);Besse, Benjamin (author);Sun, Tao (author);Martinez, Melissa (author);Sethi, Seema N (author);Shreeve, S Martin (author);Spira, Alexander I (author)
Year: 2022
DOI: 10.2217/fon-2021-0923
URL: https://doi.org/10.2217/fon-2021-0923
Download Paper from Sci-Hub:
✍: FYIcenter.com
2024-06-08, ∼756👍, 0💬
Popular Posts:
Paper Summary: Title: Determination of N-nitroso folic acid in folic acid and multivitamin supplemen...
Paper Summary: Title: International evidence on ethical mutual fund performance and investment style...
Paper Summary: Title: Interaction of light with thin liquid membranes Author(s): Patsyk, Anatoly ;Ba...
Paper Summary: Title: Sol–gel assisted incremental substitution of Ni with Ba in barium ferrichromit...
Paper Summary: Title: The Doctrine of Odious Debt In International Law (A Restatement) || Conclusion...